Trv Gp Iv, LLC 13F Filings Tracker & Analysis

CIK: 0001688325

Concentrated strategyQuality / disciplined sizing

Total reported value

$266.9M

Reporting period: 2026-03-31 · Number of holdings: 2

TRV GP IV, LLC disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $266.9M and a quarterly turnover rate of 44.2%.

Browse other institutions with $100M to $1B AUM Browse other institutions starting with "T"

Personality snowflake

Concentration: 100
Portfolio Stability: 44.21
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 4
Sizing Uniformity: 99.99

Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Add TNGX
-19.0%　$63.6M
Trim MAZE
0.0%　-$51.8M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	MAZE	Maze Therapeutics INC	Stock-Other	50.04%	-22.61%	—
2	TNGX	Tango Therapeutics INC	Stock-Other	49.96%	+22.61%	-19.05%

Portfolio Performance

Performance for Q3 2026

+5.8%

Performance Last 4 Quarters

-26.8%

Based on 50% of reported portfolio value with available pricing

Stdev: +55.1%
Beta: +1.01
Alpha: +2.3%
Max Drawdown: -42%
Annualized Perf: +8.6%
Batting Avg vs S&P: +54.5%
Sortino: +0.62
Stutzer: +0.13
Treynor: +0.23
Sterling: —
Calmar: +0.2
Information Ratio: +0.05
Tracking Error: +53.2%
Stdev Down: +38.4%
Winning Months %: +54.5%
Losing Months %: +45.5%
Best 12 Months: —
Worst 12 Months: —
Efficiency Ratio: +0.06
Sharpe: +0.43
Stdev Sectors: —
Skewness: -0.9
Kurtosis: +0.63
Upside Potential: +2.14

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	2	$266.9M	44	1MAZE 2TNGX Top holdings2026-03-31 1.MAZE 2.TNGX
2025-12-31	2	$255.1M	28	1MAZE 2TNGX Top holdings2025-12-31 1.MAZE 2.TNGX
2025-09-30	2	$274.0M	85	1MAZE 2TNGX Top holdings2025-09-30 1.MAZE 2.TNGX
2025-06-30	3	$163.3M	0	1TNGX 2MAZE 3PLRX Top holdings2025-06-30 1.TNGX 2.MAZE 3.PLRX
2025-03-31	3	$92.9M	100	1MAZE 2TNGX 3PLRX Top holdings2025-03-31 1.MAZE 2.TNGX 3.PLRX
2024-12-31	2	$80.2M	0	1TNGX 2PLRX Top holdings2024-12-31 1.TNGX 2.PLRX
2024-09-30	3	$162.1M	0	1TNGX 2PLRX 3FULC Top holdings2024-09-30 1.TNGX 2.PLRX 3.FULC
2024-06-30	3	$202.2M	0	1TNGX 2PLRX 3FULC Top holdings2024-06-30 1.TNGX 2.PLRX 3.FULC
2024-03-31	3	$206.4M	0	1TNGX 2PLRX 3FULC Top holdings2024-03-31 1.TNGX 2.PLRX 3.FULC
2023-12-31	3	$246.1M	0	1TNGX 2PLRX 3FULC Top holdings2023-12-31 1.TNGX 2.PLRX 3.FULC
2023-09-30	3	$265.4M	0	1TNGX 2PLRX 3FULC Top holdings2023-09-30 1.TNGX 2.PLRX 3.FULC
2023-06-30	3	$110.7M	0	1TNGX 2PLRX 3FULC Top holdings2023-06-30 1.TNGX 2.PLRX 3.FULC
2023-03-31	3	$139.9M	0	1TNGX 2PLRX 3FULC Top holdings2023-03-31 1.TNGX 2.PLRX 3.FULC
2022-12-31	5	$235.2M	0	1TNGX 2PLRX 3RVMD Top holdings2022-12-31 1.TNGX 2.PLRX 3.RVMD 4.FULC 5.55910K
2022-09-30	5	$171.1M	0	1TNGX 2PLRX 3RVMD Top holdings2022-09-30 1.TNGX 2.PLRX 3.RVMD 4.FULC 5.55910K
2022-06-30	5	$152.1M	0	1TNGX 2RVMD 3PLRX Top holdings2022-06-30 1.TNGX 2.RVMD 3.PLRX 4.FULC 5.55910K
2022-03-31	5	$273.0M	0	1TNGX 2FULC 3RVMD Top holdings2022-03-31 1.TNGX 2.FULC 3.RVMD 4.55910K 5.PLRX
2021-12-31	5	$347.8M	0	1TNGX 2FULC 3RVMD Top holdings2021-12-31 1.TNGX 2.FULC 3.RVMD 4.55910K 5.PLRX
2021-09-30	5	$440.7M	0	1TNGX 2FULC355910K Top holdings2021-09-30 1.TNGX 2.FULC 3.55910K 4.RVMD 5.PLRX
2021-06-30	4	$210.1M	100	155910K2PLRX 3RVMD Top holdings2021-06-30 1.55910K 2.PLRX 3.RVMD 4.FULC
2021-03-31	4	$271.5M	66	155910K2PLRX 3RVMD Top holdings2021-03-31 1.55910K 2.PLRX 3.RVMD 4.FULC
2020-12-31	5	$311.7M	9	1RLAY255910K3RVMD Top holdings2020-12-31 1.RLAY 2.55910K 3.RVMD 4.PLRX 5.FULC
2020-09-30	5	$290.5M	69	1RLAY255910K3RVMD Top holdings2020-09-30 1.RLAY 2.55910K 3.RVMD 4.PLRX 5.FULC
2020-06-30	4	$217.1M	66	1PLRX255910K3RVMD Top holdings2020-06-30 1.PLRX 2.55910K 3.RVMD 4.FULC
2020-03-31	3	$109.4M	84	155910K2RVMD 3FULC Top holdings2020-03-31 1.55910K 2.RVMD 3.FULC
2019-12-31	2	$160.4M	49	155910K2FULC Top holdings2019-12-31 1.55910K 2.FULC
2019-09-30	2	$97.7M	48	155910K2FULC Top holdings2019-09-30 1.55910K 2.FULC
2019-06-30	1	$118.1M	11	155910K Top holdings2019-06-30 1.55910K
2019-03-31	1	$131.9M	97	155910K Top holdings2019-03-31 1.55910K
2018-12-31	1	$45.6M	—	155910K Top holdings2018-12-31 1.55910K

Holding changes this quarter

Trv Gp Iv, LLC's most significant position changes for 2026-03-31: Trim: Tango Therapeutics INC (TNGX) — shares -19.05%.

Position changes disclosed by Trv Gp Iv, LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	TNGX	Tango Therapeutics INC	+22.6%	-19.05%	Trim
2	MAZE	Maze Therapeutics INC	-22.6%	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2026-03-31	2026-05-07	13F-HR	View on EDGAR
2025-12-31	2026-02-13	13F-HR	View on EDGAR
2025-09-30	2025-11-13	13F-HR	View on EDGAR
2025-06-30	2025-08-08	13F-HR	View on EDGAR
2025-03-31	2025-05-09	13F-HR	View on EDGAR
2024-12-31	2025-02-13	13F-HR	View on EDGAR
2024-09-30	2024-11-06	13F-HR	View on EDGAR
2024-06-30	2024-08-09	13F-HR	View on EDGAR
2024-03-31	2024-05-13	13F-HR	View on EDGAR
2023-12-31	2024-02-14	13F-HR	View on EDGAR
2023-09-30	2023-11-13	13F-HR	View on EDGAR
2023-06-30	2023-08-10	13F-HR	View on EDGAR
2023-03-31	2023-05-12	13F-HR	View on EDGAR
2022-12-31	2023-02-14	13F-HR	View on EDGAR
2022-09-30	2022-11-03	13F-HR	View on EDGAR
2022-06-30	2022-08-12	13F-HR	View on EDGAR
2022-03-31	2022-05-10	13F-HR	View on EDGAR
2021-12-31	2022-02-14	13F-HR	View on EDGAR
2021-09-30	2021-11-05	13F-HR	View on EDGAR
2021-06-30	2021-08-11	13F-HR	View on EDGAR
2021-03-31	2021-05-12	13F-HR	View on EDGAR
2020-12-31	2021-02-16	13F-HR	View on EDGAR
2020-09-30	2020-11-06	13F-HR	View on EDGAR
2020-06-30	2020-08-10	13F-HR	View on EDGAR
2020-03-31	2020-05-11	13F-HR	View on EDGAR
2019-12-31	2020-02-05	13F-HR	View on EDGAR
2019-09-30	2019-11-04	13F-HR	View on EDGAR
2019-06-30	2019-08-06	13F-HR	View on EDGAR
2019-03-31	2019-05-03	13F-HR	View on EDGAR
2018-12-31	2019-01-28	13F-HR	View on EDGAR

FAQ

What is Trv Gp Iv, LLC and what type of investor is it?

Trv Gp Iv, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $266.9M, spread across 2 disclosed positions.

What are Trv Gp Iv, LLC's largest equity positions?

Based on the latest 13F filing, Trv Gp Iv, LLC's top holdings by market value are: 1. Maze Therapeutics INC (MAZE) — $133.5M (50.0%) 2. Tango Therapeutics INC (TNGX) — $133.4M (50.0%)

What changes did Trv Gp Iv, LLC make in its most recent portfolio filing?

In the latest quarter, Trv Gp Iv, LLC took a more defensive posture — trimming 1 positions and completely exiting 0 holdings. The largest of these moves: Trim: Tango Therapeutics INC (TNGX) — shares -19.05%

What sectors does Trv Gp Iv, LLC focus on?

Sector breakdown data is not yet available for Trv Gp Iv, LLC. Check back after the next 13F processing cycle.

Peer Institutions

Institutions with a similar AUM

Redwood Investments, LLC

CIK 0001384058

Total reported value

$266.9M

96 stks

2025-03-31

Stale — no recent filing

Concentration7.9

Portfolio Stability100.0

Sector conviction75.4

AUM within 0.0% of this institution

View detail

Huber Financial Advisors, LLC

CIK 0001729051

Total reported value

$267.0M

114 stks

2020-03-31

Stale — no recent filing

Concentration35.5

Portfolio Stability17.7

Sector conviction86.7

AUM within 0.0% of this institution

View detail

Orland Properties Ltd

CIK 0001550093

Total reported value

$266.8M

10 stks

2026-03-31

Concentration100.0

Portfolio Stability69.1

Sector conviction100.0

AUM within 0.0% of this institution

View detail

Similar Holdings Style

Institutions with overlapping top holdings

Mass General Brigham, Inc

CIK 0001678378

Total reported value

$468.9M

6 stks

2026-03-31

Concentration100.0

Portfolio Stability60.5

Sector conviction100.0

2 of the top 5 holdings overlap, including Tango Therapeutics INC

View detail

ARCH Venture Management, LLC

CIK 0001274403

Total reported value

$677.1M

10 stks

2026-03-31

Concentration62.7

Portfolio Stability38.4

Sector conviction0.0

1 of the top 5 holdings overlap, including Maze Therapeutics INC

View detail

Acuta Capital Partners, LLC

CIK 0001582844

Total reported value

$141.8M

27 stks

2026-03-31

Concentration38.9

Portfolio Stability61.8

Sector conviction100.0

1 of the top 5 holdings overlap, including Tango Therapeutics INC

View detail

Trv Gp Iv, LLC 13F Filings Tracker & Analysis

CIK: 0001688325

Concentrated strategyQuality / disciplined sizing

Total reported value

$266.9M

Reporting period: 2026-03-31 · Number of holdings: 2

TRV GP IV, LLC disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $266.9M and a quarterly turnover rate of 44.2%.

Browse other institutions with $100M to $1B AUM Browse other institutions starting with "T"

Personality snowflake

Concentration: 100
Portfolio Stability: 44.21
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 4
Sizing Uniformity: 99.99

Recent moves

Add TNGX
-19.0%　$63.6M
Trim MAZE
0.0%　-$51.8M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	MAZE	Maze Therapeutics INC	Stock-Other	50.04%	-22.61%	—
2	TNGX	Tango Therapeutics INC	Stock-Other	49.96%	+22.61%	-19.05%

Portfolio Performance

Performance for Q3 2026

+5.8%

Performance Last 4 Quarters

-26.8%

Based on 50% of reported portfolio value with available pricing

Stdev: +55.1%
Beta: +1.01
Alpha: +2.3%
Max Drawdown: -42%
Annualized Perf: +8.6%
Batting Avg vs S&P: +54.5%
Sortino: +0.62
Stutzer: +0.13
Treynor: +0.23
Sterling: —
Calmar: +0.2
Information Ratio: +0.05
Tracking Error: +53.2%
Stdev Down: +38.4%
Winning Months %: +54.5%
Losing Months %: +45.5%
Best 12 Months: —
Worst 12 Months: —
Efficiency Ratio: +0.06
Sharpe: +0.43
Stdev Sectors: —
Skewness: -0.9
Kurtosis: +0.63
Upside Potential: +2.14

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	2	$266.9M	44	1MAZE 2TNGX Top holdings2026-03-31 1.MAZE 2.TNGX
2025-12-31	2	$255.1M	28	1MAZE 2TNGX Top holdings2025-12-31 1.MAZE 2.TNGX
2025-09-30	2	$274.0M	85	1MAZE 2TNGX Top holdings2025-09-30 1.MAZE 2.TNGX
2025-06-30	3	$163.3M	0	1TNGX 2MAZE 3PLRX Top holdings2025-06-30 1.TNGX 2.MAZE 3.PLRX
2025-03-31	3	$92.9M	100	1MAZE 2TNGX 3PLRX Top holdings2025-03-31 1.MAZE 2.TNGX 3.PLRX
2024-12-31	2	$80.2M	0	1TNGX 2PLRX Top holdings2024-12-31 1.TNGX 2.PLRX
2024-09-30	3	$162.1M	0	1TNGX 2PLRX 3FULC Top holdings2024-09-30 1.TNGX 2.PLRX 3.FULC
2024-06-30	3	$202.2M	0	1TNGX 2PLRX 3FULC Top holdings2024-06-30 1.TNGX 2.PLRX 3.FULC
2024-03-31	3	$206.4M	0	1TNGX 2PLRX 3FULC Top holdings2024-03-31 1.TNGX 2.PLRX 3.FULC
2023-12-31	3	$246.1M	0	1TNGX 2PLRX 3FULC Top holdings2023-12-31 1.TNGX 2.PLRX 3.FULC
2023-09-30	3	$265.4M	0	1TNGX 2PLRX 3FULC Top holdings2023-09-30 1.TNGX 2.PLRX 3.FULC
2023-06-30	3	$110.7M	0	1TNGX 2PLRX 3FULC Top holdings2023-06-30 1.TNGX 2.PLRX 3.FULC
2023-03-31	3	$139.9M	0	1TNGX 2PLRX 3FULC Top holdings2023-03-31 1.TNGX 2.PLRX 3.FULC
2022-12-31	5	$235.2M	0	1TNGX 2PLRX 3RVMD Top holdings2022-12-31 1.TNGX 2.PLRX 3.RVMD 4.FULC 5.55910K
2022-09-30	5	$171.1M	0	1TNGX 2PLRX 3RVMD Top holdings2022-09-30 1.TNGX 2.PLRX 3.RVMD 4.FULC 5.55910K
2022-06-30	5	$152.1M	0	1TNGX 2RVMD 3PLRX Top holdings2022-06-30 1.TNGX 2.RVMD 3.PLRX 4.FULC 5.55910K
2022-03-31	5	$273.0M	0	1TNGX 2FULC 3RVMD Top holdings2022-03-31 1.TNGX 2.FULC 3.RVMD 4.55910K 5.PLRX
2021-12-31	5	$347.8M	0	1TNGX 2FULC 3RVMD Top holdings2021-12-31 1.TNGX 2.FULC 3.RVMD 4.55910K 5.PLRX
2021-09-30	5	$440.7M	0	1TNGX 2FULC355910K Top holdings2021-09-30 1.TNGX 2.FULC 3.55910K 4.RVMD 5.PLRX
2021-06-30	4	$210.1M	100	155910K2PLRX 3RVMD Top holdings2021-06-30 1.55910K 2.PLRX 3.RVMD 4.FULC
2021-03-31	4	$271.5M	66	155910K2PLRX 3RVMD Top holdings2021-03-31 1.55910K 2.PLRX 3.RVMD 4.FULC
2020-12-31	5	$311.7M	9	1RLAY255910K3RVMD Top holdings2020-12-31 1.RLAY 2.55910K 3.RVMD 4.PLRX 5.FULC
2020-09-30	5	$290.5M	69	1RLAY255910K3RVMD Top holdings2020-09-30 1.RLAY 2.55910K 3.RVMD 4.PLRX 5.FULC
2020-06-30	4	$217.1M	66	1PLRX255910K3RVMD Top holdings2020-06-30 1.PLRX 2.55910K 3.RVMD 4.FULC
2020-03-31	3	$109.4M	84	155910K2RVMD 3FULC Top holdings2020-03-31 1.55910K 2.RVMD 3.FULC
2019-12-31	2	$160.4M	49	155910K2FULC Top holdings2019-12-31 1.55910K 2.FULC
2019-09-30	2	$97.7M	48	155910K2FULC Top holdings2019-09-30 1.55910K 2.FULC
2019-06-30	1	$118.1M	11	155910K Top holdings2019-06-30 1.55910K
2019-03-31	1	$131.9M	97	155910K Top holdings2019-03-31 1.55910K
2018-12-31	1	$45.6M	—	155910K Top holdings2018-12-31 1.55910K

Holding changes this quarter

Trv Gp Iv, LLC's most significant position changes for 2026-03-31: Trim: Tango Therapeutics INC (TNGX) — shares -19.05%.

Position changes disclosed by Trv Gp Iv, LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	TNGX	Tango Therapeutics INC	+22.6%	-19.05%	Trim
2	MAZE	Maze Therapeutics INC	-22.6%	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2026-03-31	2026-05-07	13F-HR	View on EDGAR
2025-12-31	2026-02-13	13F-HR	View on EDGAR
2025-09-30	2025-11-13	13F-HR	View on EDGAR
2025-06-30	2025-08-08	13F-HR	View on EDGAR
2025-03-31	2025-05-09	13F-HR	View on EDGAR
2024-12-31	2025-02-13	13F-HR	View on EDGAR
2024-09-30	2024-11-06	13F-HR	View on EDGAR
2024-06-30	2024-08-09	13F-HR	View on EDGAR
2024-03-31	2024-05-13	13F-HR	View on EDGAR
2023-12-31	2024-02-14	13F-HR	View on EDGAR
2023-09-30	2023-11-13	13F-HR	View on EDGAR
2023-06-30	2023-08-10	13F-HR	View on EDGAR
2023-03-31	2023-05-12	13F-HR	View on EDGAR
2022-12-31	2023-02-14	13F-HR	View on EDGAR
2022-09-30	2022-11-03	13F-HR	View on EDGAR
2022-06-30	2022-08-12	13F-HR	View on EDGAR
2022-03-31	2022-05-10	13F-HR	View on EDGAR
2021-12-31	2022-02-14	13F-HR	View on EDGAR
2021-09-30	2021-11-05	13F-HR	View on EDGAR
2021-06-30	2021-08-11	13F-HR	View on EDGAR
2021-03-31	2021-05-12	13F-HR	View on EDGAR
2020-12-31	2021-02-16	13F-HR	View on EDGAR
2020-09-30	2020-11-06	13F-HR	View on EDGAR
2020-06-30	2020-08-10	13F-HR	View on EDGAR
2020-03-31	2020-05-11	13F-HR	View on EDGAR
2019-12-31	2020-02-05	13F-HR	View on EDGAR
2019-09-30	2019-11-04	13F-HR	View on EDGAR
2019-06-30	2019-08-06	13F-HR	View on EDGAR
2019-03-31	2019-05-03	13F-HR	View on EDGAR
2018-12-31	2019-01-28	13F-HR	View on EDGAR

FAQ

What is Trv Gp Iv, LLC and what type of investor is it?

What are Trv Gp Iv, LLC's largest equity positions?

Based on the latest 13F filing, Trv Gp Iv, LLC's top holdings by market value are: 1. Maze Therapeutics INC (MAZE) — $133.5M (50.0%) 2. Tango Therapeutics INC (TNGX) — $133.4M (50.0%)

What changes did Trv Gp Iv, LLC make in its most recent portfolio filing?

What sectors does Trv Gp Iv, LLC focus on?

Sector breakdown data is not yet available for Trv Gp Iv, LLC. Check back after the next 13F processing cycle.